Therefore classification of patients into responders or nonresponders, based on clinical response and change in Ki67 index values in response to the initial therapy, seems to reflect biological characteristics rather than tumor volume expressed by clinical nodal status. This evidence concerns the gene MKI67 and neoplasm.